<meta http-equiv="Content-Type" content="text/html;charset=utf-8" /><!DOCTYPE doctype html>
<html class="Unknown 0_0 Unknown Unknown titanDisplay" id="htmlTag" xmlns="http://www.w3.org/1999/xhtml">
 <head>
  <link href="/ClientCss/style_eperc.css" rel="stylesheet" type="text/css"/>
  <meta content="Titan CMS" name="creator"/>
  <title id="pageTitle">
   # 215 Opioid Poorly Responsive Cancer Pain
  </title>
  <meta content="72902" name="DocID">
   <meta content="# 215 Opioid Poorly Responsive Cancer Pain" name="Title">
    <meta content="# 215 Opioid Poorly Responsive Cancer Pain, Communication, Medical Knowledge, Pain – Evaluation, Pain – Opioids, Patient Care, Prognosis" name="Keywords">
     <meta content="Relief of cancer pain from opioids is rarely all or nothing; most patients experience some degree of analgesia alongside opioid toxicities. While opioid poorly-responsive pain is not a discreet syndrome, it is a commonly encountered clinical scenario. This Fast Fact reviews key points in its assessment and management." name="Description">
      <meta content="Relief of cancer pain from opioids is rarely all or nothing; most patients experience some degree of analgesia alongside opioid toxicities. While opioid poorly-responsive pain is not a discreet syndrome, it is a commonly encountered clinical scenario. This Fast Fact reviews key points in its assessment and management." name="Abstract">
       <link href="/display/WhatsNew.rss" rel="alternate+rss" title="RSS" type="application/rss+xml"/>
       <script src="/Scripts/titanscripts.js" type="text/javascript">
       </script>
       <script src="/Scripts/Banner.js" type="text/javascript">
       </script>
       <script src="http://www.google.com/recaptcha/api/js/recaptcha_ajax.js" type="text/javascript">
       </script>
       <script src="/commonScripts/mcwCommon.js" type="text/javascript">
       </script>
       <script type="text/javascript">
        var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
       </script>
       <script type="text/javascript">
        try {
var pageTracker = _gat._getTracker("UA-11124256-1");
pageTracker._trackPageview();
} catch(err) {}
       </script>
      </meta>
     </meta>
    </meta>
   </meta>
  </meta>
 </head>
 <body class="titanBody" id="bodyTag" onclick="if (window['TitanClickHandler']) TitanClickHandler(this, event)" onload="TitanLoad();">
  <form action="/EPERC/FastFactsIndex/ff_215.htm?" enctype="multipart/form-data" id="routerForm" method="post" name="routerForm">
   <input id="__VIEWSTATE" name="__VIEWSTATE" type="hidden" value="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"/>
   <script src="/ScriptResource.axd?d=xFDxeqDolrWHepB5BOa6WusqXFLn3wro2JYAUSW54WCZIM7tlRS9tbqUciiQ66IHFJNcNWN3CVU9VVXPPRcSENg7qOCQHN4cE4-dXQ8bxlvvzOwDdwbXgIu1gG27qPOQ1CQrIgFe_q5BlrAijrvDUgIWykSGToLqgYeMH1AtHUs1&amp;t=ffffffff940d030f" type="text/javascript">
   </script>
   <script src="/display/components/Blocks/Commenting/Support/CommentingAjax.asmx/js" type="text/javascript">
   </script>
   <div id="mainBody">
    <!--/pageTopArea -->
    <div id="contentArea">
     <div id="contentContainer">
      <!--/toolContainer -->
      <div id="centerZone">
       <div id="titleBarContainer">
        <h1>
         # 215 Opioid Poorly Responsive Cancer Pain
        </h1>
       </div>
       <!--/titleBarContainer -->
       <div blockinfo="Freeform CenterZone BlockID1" class="Freeform CenterZone BlockID1">
        <p>
         <strong>
          <a href="./ff_215.htm" linktype="4" target="_blank">
           FAST FACTS AND CONCEPTS #215 PDF
          </a>
         </strong>
        </p>
        <p>
         <b>
          Author(s):
         </b>
         Tamara Sacks MD, David E Weissman MD, and Robert Arnold MD
        </p>
        <p>
         <b>
          Background
         </b>
         Relief of cancer pain from opioids is rarely all or nothing; most patients experience some degree of analgesia alongside opioid toxicities. When the balance of analgesia versus toxicity tips away from analgesia, the term ‘opioid poorly-responsive pain’ is invoked. While opioid poorly-responsive pain is not a discreet syndrome, it is a commonly encountered clinical scenario. This Fast Fact reviews key points in its assessment and management.
        </p>
        <p>
         <b>
          Differential Diagnosis of Opioid Poorly-Responsive Pain
         </b>
        </p>
        <ol>
         <li>
          Cancer-related pain
          <ol type="a">
           <li>
            Cancer progression (new fracture at site of known bone metastases).
           </li>
           <li>
            Causes of pain (eg. neuropathic pain, skin ulceration, rectal tenesmus, muscle pain) that are known to be less responsive to systemic opioids or opioid monotherapy.
           </li>
           <li>
            Psychological/spiritual pain related to the cancer experience (existential pain of impending death).
           </li>
          </ol>
         </li>
         <li>
          Opioid pharmacology/technical problems
          <ol type="a">
           <li>
            Opioid tolerance (rapid dose escalation with no analgesic effect).
           </li>
           <li>
            Dose-limiting opioid toxicity (sedation, delirium, hyperalgesia, nausea –
            <a href="./ff_025.htm" linktype="4" target="_blank">
             see
             <i>
              Fast Facts
             </i>
             #25
            </a>
            ,
            <a href="./ff_142.htm" linktype="4" target="_blank">
             142
            </a>
            ).
           </li>
           <li>
            Poor oral absorption (for PO meds) or skin absorption (e.g. transdermal patch adhesive failure).
           </li>
           <li>
            Pump, needle, or catheter problems (IV, subcutaneous, or spinal opioids).
           </li>
          </ol>
         </li>
         <li>
          Non-cancer pain
          <ol type="a">
           <li>
            Worsening of a known non-cancer pain syndrome (diabetic neuropathy).
           </li>
           <li>
            New non-cancer pain syndrome (dental abscess).
           </li>
          </ol>
         </li>
         <li>
          Other psychological problems
          <ol type="a">
           <li>
            Depression, anxiety, somatization, hypochondria, factitious disorders.
           </li>
           <li>
            Dementia and delirium both can effect a patient’s report of and experience of pain.
           </li>
           <li>
            Opioid substance use disorders or opioid diversion.
           </li>
          </ol>
         </li>
        </ol>
        <p>
         <b>
          Management Strategy
         </b>
        </p>
        <ol>
         <li>
          Initial Steps
          <ol type="a">
           <li>
            Complete a thorough pain assessment including questions exploring psychological and spiritual concerns. If substance abuse or diversion is suspected, complete a substance abuse history (
            <a href="./ff_068.htm" linktype="4" target="_blank">
             see
             <i>
              Fast Facts
             </i>
             #68
            </a>
            ,
            <a href="./ff_069.htm" linktype="4" target="_blank">
             69
            </a>
            ).
           </li>
           <li>
            Complete a physical examination and order diagnostic studies as indicated.
           </li>
           <li>
            Escalate a single opioid until acceptable analgesia or unacceptable toxicity develop, or it is clear that additional analgesic benefit is not being derived from dose escalation. If this fails, consider:
            <ol type="i">
             <li>
              Rotating to a different opioid (e.g. morphine to methadone).
             </li>
             <li>
              Changing the route of administration (e.g. oral to subcutaneous).
             </li>
            </ol>
           </li>
           <li>
            Treat opioid toxicities aggressively.
           </li>
           <li>
            Use (start or up-titrate) adjuvant analgesics, especially for neuropathic pain syndromes.
           </li>
           <li>
            Integrate non-pharmacological treatments such as behavioral therapies, physical modalities like heat and cold, and music and other relaxation-based therapies –
            <a href="./ff_211.htm" linktype="4" target="_blank">
             see
             <i>
              Fast Fact
             </i>
             #211
            </a>
            .
           </li>
          </ol>
         </li>
         <li>
          Additional steps – Pain refractory to the initial steps requires multi-disciplinary input and care coordination.
          <ol type="a">
           <li>
            Hospice/Palliative Medicine consultation to optimize pain assessment, drug management, and assessment of overall care goals.
           </li>
           <li>
            Mental health consultation for help in diagnosis and management of suspected psychological factors contributing to pain.
           </li>
           <li>
            Chaplain/Clergy assistance for suspected spiritual factors contributing to pain.
           </li>
           <li>
            Interventional Pain and/or Radiation Oncology consultation.
           </li>
           <li>
            Rehabilitation consultations (Physiatry, Physical and Occupational Therapy) to maximize physical analgesic modalities.
           </li>
           <li>
            Pharmacist assistance with drug/route information.
           </li>
          </ol>
         </li>
        </ol>
        <p>
         <b>
          References
         </b>
        </p>
        <ol>
         <li>
          Mercadante F, Portenoy RK. Opiate Poorly Responsive Cancer Pain Parts 1-3. J Pain Symptom Management. 2001; 21(2):144-150, 21(3):255-264, 24(4):338-354.
         </li>
         <li>
          Smith TJ, Staats PS, Deer T, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002; 20(19):4040-9.
         </li>
         <li>
          Fallon M. When morphine does not work. Support Care Cancer. 2008; 16(7):771-5.
         </li>
         <li>
          Quigley C. Opioid switching to improve pain relief and drug tolerability. Cochrane Database of Systematic Reviews. 2004, Issue 3. Art. No.: CD004847. DOI: 10.1002/14651858.CD004847.
         </li>
         <li>
          Hanks GW. Opioid-responsive and opioid-non-responsive pain in cancer. Br Med Bull. 1991; 47(3):718-31.
         </li>
         <li>
          Hanks G, Forbes K. Opioid responsiveness. Acta Anaesthesiologica Scand.1997; 41:154-158.
         </li>
        </ol>
        <p>
         <b>
          Author Affiliations:
         </b>
         University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (TS, RA), and Medical College of Wisconsin, Milwaukee, Wisconsin (DEW).
        </p>
        <p>
         <b>
          Fast Facts and Concepts
         </b>
         are edited by Drew A Rosielle MD, Palliative Care Center, Medical College of Wisconsin. For more information write to:
         <a href='javascript:window.alert("Links%20are%20not%20available%20in%20preview.");' linktype="5">
          drosiell@mcw.edu
         </a>
         . More information, as well as the complete set of Fast Facts, are available at EPERC:
         <span style="text-decoration: underline">
         </span>
         <a href='javascript:window.alert("Links%20are%20not%20available%20in%20preview.");' linktype="3">
          www.eperc.mcw.edu.
         </a>
         <br/>
         Comments and questions about this and other Fast Facts should be directed to the Fast Facts and Concepts Discussion Blog at
         <a href='javascript:window.alert("Links%20are%20not%20available%20in%20preview.");' linktype="3">
          http://epercfastfacts.blogspot.com
         </a>
         .
        </p>
        <p>
         <b>
          Version History:
         </b>
         Originally published May 2009.
        </p>
        
        <p>
         <b>
          Disclaimer:
         </b>
         Fast Facts and Concepts provide educational information. This information is not medical advice. Health care providers should exercise their own independent clinical judgment. Some Fast Facts cite the use of a product in a dosage, for an indication, or in a manner other than that recommended in the product labeling. Accordingly, the official prescribing information should be consulted before any such product is used.
        </p>
        <p>
         <b>
          ACGME Competencies:
         </b>
         Medical Knowledge, Patient Care
        </p>
        <p>
         <b>
          Keywords:
         </b>
         Communication, Pain – Evaluation, Pain – Opioids, Prognosis
        </p>
       </div>
      </div>
      <!--/centerZone -->
      <div id="rightZone">
      </div>
      <!--/rightZone -->
     </div>
     <!--/contentContainer -->
    </div>
    <!-- /contentArea -->
    <!--/bottomContainer -->
   </div>
   <!--/mainBody -->
   <input air="flowplayer.controls-air-3.2.12.swf" basedir="/display/components/Blocks/Freeform_CK/ckeditor/plugins/titanflowplayer/" id="flowPlayerSettings" js="flowplayer-3.2.11.min.js" modern="flowplayer.controls-3.2.12.swf" pseudo="flowplayer.pseudostreaming-3.2.9.swf" swf="flowplayer-3.2.12.swf" tube="flowplayer.controls-tube-3.2.12.swf" type="hidden"/>
  </form>
 </body>
</html>
